PMID: 3747027Oct 1, 1986Paper

Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro

Journal of Virology
H FanP K Pattengale

Abstract

The effects of rearrangement and insertion of sequences in the Moloney murine leukemia virus (M-MuLV) long terminal repeat (LTR) were investigated. The alterations were made by recombinant DNA manipulations on a plasmid subclone containing an M-MuLV LTR. Promoter activity of altered LTRs was measured by fusion to the bacterial chloramphenicol acetyltransferase gene, followed by transient expression assay in NIH 3T3 cells. M-MuLV proviral organizations containing the altered LTRs were also generated, and infectious virus was recovered by transfection. Infectivity of the resulting virus was quantified by XC plaque assay, and pathogenicity was determined by inoculating neonatal NIH Swiss mice. Inversion of sequences in the U3 region containing the tandemly repeated enhancer sequences (-150 to -353 base pairs [bp]) reduced promoter activity approximately fivefold in the transient-expression assays. Infectious virus containing the inverted sequences (Mo- M-MuLV) showed a 20-fold reduction in relative infectivity compared with wild-type M-MuLV, but the virus still induced thymus-derived lymphoblastic lymphoma or leukemia in mice, with essentially the same kinetics as for wild-type M-MuLV. We previously derived an M-MuLV which carried...Continue Reading

References

Feb 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J W HartleyW P Rowe
Dec 1, 1970·Virology·W P RoweJ W Hartley
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·Y LiN Hopkins
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·L A LaiminsP Gruss
Jun 1, 1983·Cell·G Khoury, P Gruss
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·L DesGroseillersP Jolicoeur
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P A ChatisN Hopkins
Sep 1, 1983·Journal of Virology·W J MullerJ A Hassell
Sep 1, 1982·Molecular and Cellular Biology·C M GormanB H Howard

❮ Previous
Next ❯

Citations

Dec 11, 1990·Biochimica Et Biophysica Acta·M van Lohuizen, A Berns

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

BK Virus Infection

BK virus infection is a significant complication of modern immunosuppression used in kidney transplantation. Discover the latest research on BK virus infection here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.